HEADER HYDROLASE 28-MAY-11 2YKN TITLE CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX WITH TITLE 2 A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER DERIVATIVE, A TITLE 3 NON-NUCLEOSIDE RT INHIBITOR (NNRTI) CAVEAT 2YKN PHE A 346 C-ALPHA IS PLANAR COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 600-1156; COMPND 5 SYNONYM: EXORIBONUCLEASE H, P66RT; COMPND 6 EC: 2.7.7.49 , 2.7.7.7 , 3.1.26.13; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: REVERSE TRANSCRIPTASE/RIBONUCLEASE H; COMPND 11 CHAIN: B; COMPND 12 FRAGMENT: RESIDUES 600-1027; COMPND 13 SYNONYM: EXORIBONUCLEASE H, P66RT; COMPND 14 EC: 2.7.7.49 , 2.7.7.7 , 3.1.26.13; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 3 ORGANISM_TAXID: 11678; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BH10; SOURCE 8 ORGANISM_TAXID: 11678; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.BOYER,E.ARNOULT,M.MEDEBIELLE,J.GUILLEMONT,T.UNGE,J.UNGE,D.JOCHMANS REVDAT 4 01-MAY-24 2YKN 1 REMARK LINK REVDAT 3 17-JAN-18 2YKN 1 REMARK REVDAT 2 14-DEC-11 2YKN 1 JRNL REVDAT 1 17-AUG-11 2YKN 0 JRNL AUTH J.BOYER,E.ARNOULT,M.MEDEBIELLE,J.GUILLEMONT,J.UNGE, JRNL AUTH 2 D.JOCHMANS JRNL TITL DIFLUOROMETHYLBENZOXAZOLE PYRIMIDINE THIOETHER DERIVATIVES: JRNL TITL 2 A NOVEL CLASS OF POTENT NON-NUCLEOSIDE HIV-1 REVERSE JRNL TITL 3 TRANSCRIPTASE INHIBITORS. JRNL REF J.MED.CHEM. V. 54 7974 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 22017513 JRNL DOI 10.1021/JM200766B REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 92.6 REMARK 3 NUMBER OF REFLECTIONS : 70963 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3764 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.12 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.17 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4588 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 82.20 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 229 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7878 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 276 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.52 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.05000 REMARK 3 B22 (A**2) : -0.98000 REMARK 3 B33 (A**2) : 2.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.233 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.209 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.146 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.440 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.939 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.912 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8134 ; 0.023 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11064 ; 2.235 ; 1.966 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 967 ; 7.698 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 353 ;38.892 ;25.467 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1478 ;19.548 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;15.357 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1203 ; 0.173 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6067 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4853 ; 1.292 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 7938 ; 2.350 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3281 ; 3.249 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3124 ; 5.298 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 2YKN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 28-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1290048456. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03790 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH SX-165 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 74751 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 19.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.0 REMARK 200 DATA REDUNDANCY : 5.700 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: REVERSE TRANSCRIPTASE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 76.38200 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 76.38200 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 59.52300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 77.78800 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 59.52300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 77.78800 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 76.38200 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 59.52300 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 77.78800 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 76.38200 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 59.52300 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 77.78800 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44890 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -33.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, PHE 826 TO LEU REMARK 400 ENGINEERED RESIDUE IN CHAIN A, GLU1077 TO GLN REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 559 REMARK 465 HIS A 560 REMARK 465 HIS A 561 REMARK 465 HIS A 562 REMARK 465 LYS B 219 REMARK 465 LYS B 220 REMARK 465 HIS B 221 REMARK 465 GLN B 222 REMARK 465 LYS B 223 REMARK 465 GLU B 224 REMARK 465 PRO B 225 REMARK 465 PRO B 226 REMARK 465 PHE B 227 REMARK 465 LEU B 228 REMARK 465 TRP B 229 REMARK 465 MET B 230 REMARK 465 GLY B 231 REMARK 465 ARG B 358 REMARK 465 GLY B 359 REMARK 465 ALA B 360 REMARK 465 HIS B 361 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 356 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 358 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 448 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 556 CB CG1 CG2 CD1 REMARK 470 ARG A 557 CG CD NE CZ NH1 NH2 REMARK 470 HIS A 558 CA C O CB CG ND1 CD2 REMARK 470 HIS A 558 CE1 NE2 REMARK 470 ILE B 2 CG1 CG2 CD1 REMARK 470 THR B 69 OG1 CG2 REMARK 470 ASP B 218 CG OD1 OD2 REMARK 470 GLN B 428 CA C O CB CG CD OE1 REMARK 470 GLN B 428 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR B 427 N GLN B 428 1.40 REMARK 500 O PRO B 420 O PRO B 421 1.68 REMARK 500 N ASP B 364 O HOH B 2106 1.70 REMARK 500 O HOH A 2008 O HOH A 2015 1.77 REMARK 500 O ASN B 363 O HOH A 2134 1.78 REMARK 500 O LYS A 451 O THR A 470 1.87 REMARK 500 O HOH A 2100 O HOH A 2101 1.94 REMARK 500 O HOH A 2048 O HOH A 2110 1.99 REMARK 500 O HOH B 2042 O HOH B 2093 2.09 REMARK 500 CH2 TRP B 266 OH TYR B 427 2.11 REMARK 500 OH TYR B 354 OE1 GLU B 370 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 VAL A 10 CB VAL A 10 CG1 -0.135 REMARK 500 SER A 57 CB SER A 57 OG 0.078 REMARK 500 VAL A 90 CB VAL A 90 CG2 0.156 REMARK 500 ARG B 143 CG ARG B 143 CD -0.175 REMARK 500 VAL B 148 CB VAL B 148 CG1 0.128 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU A 100 CB - CG - CD1 ANGL. DEV. = 10.3 DEGREES REMARK 500 VAL A 108 CB - CA - C ANGL. DEV. = -11.8 DEGREES REMARK 500 GLY A 152 C - N - CA ANGL. DEV. = -15.3 DEGREES REMARK 500 ASP A 185 CB - CG - OD1 ANGL. DEV. = -9.4 DEGREES REMARK 500 LEU A 187 CB - CG - CD1 ANGL. DEV. = 11.1 DEGREES REMARK 500 PRO A 225 C - N - CA ANGL. DEV. = 13.1 DEGREES REMARK 500 PRO A 243 C - N - CA ANGL. DEV. = -16.8 DEGREES REMARK 500 PHE A 346 C - N - CA ANGL. DEV. = 19.0 DEGREES REMARK 500 PHE A 346 CB - CA - C ANGL. DEV. = 12.6 DEGREES REMARK 500 LEU A 484 CA - CB - CG ANGL. DEV. = 15.1 DEGREES REMARK 500 GLY B 152 C - N - CA ANGL. DEV. = -14.7 DEGREES REMARK 500 PRO B 420 C - N - CD ANGL. DEV. = -14.8 DEGREES REMARK 500 PRO B 421 C - N - CA ANGL. DEV. = -11.3 DEGREES REMARK 500 TYR B 427 CA - C - O ANGL. DEV. = -38.4 DEGREES REMARK 500 TYR B 427 CA - C - N ANGL. DEV. = 34.8 DEGREES REMARK 500 TYR B 427 O - C - N ANGL. DEV. = -52.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 54 109.19 -35.80 REMARK 500 PRO A 55 -161.41 -79.55 REMARK 500 TYR A 56 126.93 77.19 REMARK 500 TRP A 71 139.29 95.48 REMARK 500 GLU A 89 -124.11 70.84 REMARK 500 VAL A 90 -52.37 160.72 REMARK 500 GLN A 91 133.51 161.83 REMARK 500 LEU A 92 57.64 -152.51 REMARK 500 GLU A 122 -53.98 113.43 REMARK 500 ASN A 137 20.81 47.35 REMARK 500 MET A 184 -123.18 52.51 REMARK 500 ASP A 218 85.32 -52.52 REMARK 500 LYS A 220 49.09 31.67 REMARK 500 HIS A 221 73.98 52.72 REMARK 500 GLN A 222 -103.70 -58.56 REMARK 500 LYS A 223 131.41 -17.63 REMARK 500 PRO A 225 -56.31 -14.42 REMARK 500 PRO A 243 -106.37 -152.42 REMARK 500 ILE A 244 75.43 89.00 REMARK 500 ILE A 270 -20.85 -140.85 REMARK 500 THR A 286 102.69 -2.36 REMARK 500 ALA A 288 -112.14 116.16 REMARK 500 LEU A 289 -42.33 -173.44 REMARK 500 LYS A 311 -85.39 -26.08 REMARK 500 GLN A 334 -69.85 -107.56 REMARK 500 PHE A 346 -7.06 72.50 REMARK 500 ARG A 356 144.04 -9.01 REMARK 500 PRO A 412 173.76 -57.22 REMARK 500 ARG A 448 -36.45 88.09 REMARK 500 THR A 470 -89.03 -110.98 REMARK 500 ILE A 556 -94.80 -41.51 REMARK 500 ARG A 557 -16.60 -141.12 REMARK 500 ILE B 2 59.20 -165.27 REMARK 500 LYS B 66 -115.67 -136.38 REMARK 500 THR B 69 -79.11 -60.44 REMARK 500 GLU B 89 -10.87 64.40 REMARK 500 MET B 184 -120.72 52.47 REMARK 500 GLU B 233 104.94 132.76 REMARK 500 VAL B 241 -105.86 -89.52 REMARK 500 GLN B 242 56.86 20.66 REMARK 500 PRO B 243 -104.87 -85.11 REMARK 500 ILE B 244 111.34 -23.43 REMARK 500 TRP B 252 -68.20 -140.63 REMARK 500 LYS B 275 -75.03 -112.75 REMARK 500 VAL B 276 -21.16 77.34 REMARK 500 LEU B 282 -38.83 108.61 REMARK 500 THR B 286 72.25 -150.12 REMARK 500 THR B 296 97.48 179.05 REMARK 500 GLU B 297 -65.04 -149.55 REMARK 500 ASN B 363 -84.35 120.49 REMARK 500 REMARK 500 THIS ENTRY HAS 55 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 TRP A 88 GLU A 89 144.31 REMARK 500 LEU B 295 THR B 296 149.86 REMARK 500 VAL B 417 ASN B 418 -144.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 TYR B 427 176.25 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A1560 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 443 OD1 REMARK 620 2 GLY A 444 O 67.1 REMARK 620 3 GLN A 478 OE1 124.6 77.3 REMARK 620 4 ASP A 498 OD1 103.6 165.3 117.2 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE YKN A 1559 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 1560 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VG7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH REMARK 900 THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS REMARK 900 RELATED ID: 1AJV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC SULFAMIDE INHIBITOR AHA006 REMARK 900 RELATED ID: 1HAR RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (AMINO-TERMINAL HALF) (FINGERS AND PALM REMARK 900 SUBDOMAINS) (RT216) REMARK 900 RELATED ID: 1HPS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SB206343 REMARK 900 RELATED ID: 1T7K RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITHARYLSULFONAMIDE REMARK 900 AZACYCLIC UREA REMARK 900 RELATED ID: 1D4J RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSL370 REMARK 900 RELATED ID: 1R0A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE COVALENTLYTETHERED REMARK 900 TO DNA TEMPLATE-PRIMER SOLVED TO 2. 8 ANGSTROMS REMARK 900 RELATED ID: 1HPZ RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 2VG6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH REMARK 900 THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS REMARK 900 RELATED ID: 1HQE RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1QE1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF 3TC-RESISTANT M184I MUTANT OF HIV -1 REVERSE REMARK 900 TRANSCRIPTASE REMARK 900 RELATED ID: 1NPA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE-HUP REMARK 900 RELATED ID: 1AJX RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE CYCLIC UREA INHIBITOR AHA001 REMARK 900 RELATED ID: 1EBK RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 REMARK 900 PROTEASE REMARK 900 RELATED ID: 1TVR RELATED DB: PDB REMARK 900 HIV-1 RT/9-CL TIBO REMARK 900 RELATED ID: 1S6P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1REVERSE REMARK 900 TRANSCRIPTASE (RT) IN COMPLEX WITH JANSSEN- R100943 REMARK 900 RELATED ID: 1IKV RELATED DB: PDB REMARK 900 K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFIVARENZ REMARK 900 RELATED ID: 1BQM RELATED DB: PDB REMARK 900 HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1W5Y RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1HOS RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH SB204144 REMARK 900 RELATED ID: 1IKW RELATED DB: PDB REMARK 900 WILD TYPE HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHEFAVIRENZ REMARK 900 RELATED ID: 1S6Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN-R147681 REMARK 900 RELATED ID: 3HVT RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1EC1 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA409 REMARK 900 RELATED ID: 1EC0 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA403 REMARK 900 RELATED ID: 2XYF RELATED DB: PDB REMARK 900 HIV-1 INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION- REMARK 900 STATE MIMIC AND VARIOUS P2 AND P1 PRIME SUBSTITUENTS REMARK 900 RELATED ID: 1T05 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TEMPLATE- PRIMERWITH REMARK 900 TENOFOVIR-DIPHOSPHATE BOUND AS THE INCOMINGNUCLEOTIDE SUBSTRATE REMARK 900 RELATED ID: 1RVQ RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 TIBO (THEORETICAL MODEL) REMARK 900 RELATED ID: 1D4I RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA425 REMARK 900 RELATED ID: 1MEU RELATED DB: PDB REMARK 900 HIV-1 MUTANT (V82F, I84V) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1S9G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN-R120394. REMARK 900 RELATED ID: 2BE2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH R221239 REMARK 900 RELATED ID: 1HNV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (HIV-1 RT) MUTANT WITH CYS 280 REPLACED REMARK 900 BY SER (C280S) REMARK 900 RELATED ID: 1RVR RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 IMIDAZODIPYRIDODIAZEPINE (UK-129,485) ( THEORETICAL MODEL) REMARK 900 RELATED ID: 1IKX RELATED DB: PDB REMARK 900 K103N MUTANT HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITHTHE REMARK 900 INHIBITOR PNU142721 REMARK 900 RELATED ID: 1W5W RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1IKY RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITORMSC194 REMARK 900 RELATED ID: 1QMC RELATED DB: PDB REMARK 900 C-TERMINAL DNA-BINDING DOMAIN OF HIV-1 INTEGRASE, NMR, 42 STRUCTURES REMARK 900 RELATED ID: 1N6Q RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO PRE- TRANSLOCATION AZTMP- REMARK 900 TERMINATED DNA (COMPLEX N) REMARK 900 RELATED ID: 1D4H RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA435 REMARK 900 RELATED ID: 1RVN RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 PHENYL-ISOINDOLINONE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1HBV RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SB203238 REMARK 900 RELATED ID: 1HTF RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR126045 REMARK 900 RELATED ID: 1RTD RELATED DB: PDB REMARK 900 STRUCTURE OF A CATALYTIC COMPLEX OF HIV-1 REVERSE TRANSCRIPTASE: REMARK 900 IMPLICATIONS FOR NUCLEOSIDE ANALOG DRUG RESISTANCE REMARK 900 RELATED ID: 1EC2 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA428 REMARK 900 RELATED ID: 2HMI RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH A DOUBLE- STRANDED REMARK 900 DEOXYRIBONUCLEIC ACID AND FAB28 REMARK 900 RELATED ID: 1W5V RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1SV5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF K103N MUTANT HIV-1 REVERSETRANSCRIPTASE (RT) REMARK 900 IN COMPLEX WITH JANSSEN-R165335 REMARK 900 RELATED ID: 2UY0 RELATED DB: PDB REMARK 900 TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY- REMARK 900 ALCOHOL-CONTAINING TRANSITION-STATE MIMIC REMARK 900 RELATED ID: 1HMV RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 2BBB RELATED DB: PDB REMARK 900 STRUCTURE OF HIV1 PROTEASE AND HH1_173_3A COMPLEX. REMARK 900 RELATED ID: 1S9E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN-R129385 REMARK 900 RELATED ID: 2X4U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO HIV-1 PEPTIDE REMARK 900 RT468-476 REMARK 900 RELATED ID: 1N5Y RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO POST- TRANSLOCATION REMARK 900 AZTMP-TERMINATED DNA (COMPLEX P) REMARK 900 RELATED ID: 1DLO RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 1HEG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SKF 107457 (HEG) REMARK 900 RELATED ID: 1RVP RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 THIAZOLOISOINDOLINONE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1RVL RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 ALPHA-APA (R89439) (THEORETICAL MODEL) REMARK 900 RELATED ID: 1DW6 RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1 REMARK 900 PROTEASE REMARK 900 RELATED ID: 1EET RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE IN COMPLEX WITH THE INHIBITOR MSC204 REMARK 900 RELATED ID: 1W5X RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH FLUORO SUBSTITUTED DIOL -BASED C2- REMARK 900 SYMMETRIC INHIBITOR REMARK 900 RELATED ID: 1YT9 RELATED DB: PDB REMARK 900 HIV PROTEASE WITH OXIMINOARYLSULFONAMIDE BOUND REMARK 900 RELATED ID: 2B6A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH THR-50 REMARK 900 RELATED ID: 1HTG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR137615 REMARK 900 RELATED ID: 1HVU RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE COMPLEXED REMARK 900 WITH A 33-BASE NUCLEOTIDE RIBONUCLEIC ACID PSEUDOKNOT REMARK 900 RELATED ID: 1EBW RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA322 REMARK 900 RELATED ID: 2BAN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN-R157208 REMARK 900 RELATED ID: 1RDH RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE (RIBONUCLEASE H DOMAIN) REMARK 900 RELATED ID: 2XYE RELATED DB: PDB REMARK 900 HIV-1 INHIBITORS WITH A TERTIARY-ALCOHOL-CONTAINING TRANSITION- REMARK 900 STATE MIMIC AND VARIOUS P2 AND P1 PRIME SUBSTITUENTS REMARK 900 RELATED ID: 1EBY RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA369 REMARK 900 RELATED ID: 1J5O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MET184ILE MUTANT OF HIV-1 REVERSETRANSCRIPTASE REMARK 900 IN COMPLEX WITH DOUBLE STRANDED DNA TEMPLATE-PRIMER REMARK 900 RELATED ID: 1RVO RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 NEVIRAPINE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1HVP RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEX WITH SUBSTRATE (THEORETICAL MODEL) REMARK 900 RELATED ID: 1MES RELATED DB: PDB REMARK 900 HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1EC3 RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR MSA367 REMARK 900 RELATED ID: 1HEF RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH SKF 108738 (HEF) REMARK 900 RELATED ID: 1HIH RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH INHIBITOR CGP 53820 REMARK 900 RELATED ID: 1HNI RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE (HIV-1RT) REMARK 900 MUTANT WITH CYS 280 REPLACED BY SER (C280S) REMARK 900 RELATED ID: 1TV6 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE COMPLEXED WITH CP-94,707 REMARK 900 RELATED ID: 1A9M RELATED DB: PDB REMARK 900 G48H MUTANT OF HIV-1 PROTEASE IN COMPLEX WITH A PEPTIDIC INHIBITOR REMARK 900 U-89360E REMARK 900 RELATED ID: 1EBZ RELATED DB: PDB REMARK 900 HIV-1 PROTEASE IN COMPLEX WITH THE INHIBITOR BEA388 REMARK 900 RELATED ID: 2B5J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN-R165481 REMARK 900 RELATED ID: 1HYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE IN COMPLEXWITH A REMARK 900 POLYPURINE TRACT RNA:DNA REMARK 900 RELATED ID: 1MET RELATED DB: PDB REMARK 900 HIV-1 MUTANT (V82F) PROTEASE COMPLEXED WITH DMP323 REMARK 900 RELATED ID: 1T03 RELATED DB: PDB REMARK 900 HIV-1 REVERSE TRANSCRIPTASE CROSSLINKED TO TENOFOVIRTERMINATED REMARK 900 TEMPLATE-PRIMER (COMPLEX P) REMARK 900 RELATED ID: 1AXA RELATED DB: PDB REMARK 900 ACTIVE-SITE MOBILITY IN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 PROTEASE AS DEMONSTRATED BY CRYSTAL STRUCTURE OF A28S MUTANT REMARK 900 RELATED ID: 1MER RELATED DB: PDB REMARK 900 HIV-1 MUTANT (I84V) PROTEASE COMPLEXED WITH DMP450 REMARK 900 RELATED ID: 1NPW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV PROTEASE COMPLEXED WITH LGZ479 REMARK 900 RELATED ID: 3TLH RELATED DB: PDB REMARK 900 STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITHAN REMARK 900 EFFICIENT INHIBITOR OF FIV PR REMARK 900 RELATED ID: 1SUQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) INCOMPLEX REMARK 900 WITH JANSSEN-R185545 REMARK 900 RELATED ID: 2UXZ RELATED DB: PDB REMARK 900 TWO-CARBON-ELONGATED HIV-1 PROTEASE INHIBITORS WITH A TERTIARY- REMARK 900 ALCOHOL-CONTAINING TRANSITION-STATE MIMIC REMARK 900 RELATED ID: 1HVK RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR A76928 (S, S) REMARK 900 RELATED ID: 1SBG RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH THE INHIBITOR SB203386 REMARK 900 RELATED ID: 1BQN RELATED DB: PDB REMARK 900 TYR 188 LEU HIV-1 RT/HBY 097 REMARK 900 RELATED ID: 1UWB RELATED DB: PDB REMARK 900 TYR 181 CYS HIV-1 RT/8-CL TIBO REMARK 900 RELATED ID: 2VG5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HIV-1 REVERSE TRANSCRIPTASE COMPLEXES WITH REMARK 900 THIOCARBAMATE NON-NUCLEOSIDE INHIBITORS REMARK 900 RELATED ID: 1RVM RELATED DB: PDB REMARK 900 REVERSE TRANSCRIPTASE NON-NUCLEOSIDE BINDING SITE COMPLEXED WITH REMARK 900 HEPT (THEORETICAL MODEL) REMARK 900 RELATED ID: 1HTE RELATED DB: PDB REMARK 900 HIV-1 PROTEASE COMPLEXED WITH GR123976 REMARK 900 RELATED ID: 1HRH RELATED DB: PDB REMARK 900 RIBONUCLEASE H DOMAIN OF HIV-1 REVERSE TRANSCRIPTASE REMARK 900 RELATED ID: 1NPV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 PROTEASE COMPLEXED WITH LDC271 REMARK 900 RELATED ID: 1HQU RELATED DB: PDB REMARK 900 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REMARK 900 RELATED ID: 2YKM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HIV-1 REVERSE TRANSCRIPTASE (RT) IN COMPLEX REMARK 900 WITH A DIFLUOROMETHYLBENZOXAZOLE (DFMB) PYRIMIDINE THIOETHER REMARK 900 DERIVATIVE, A NON-NUCLEOSIDE RT INHIBITOR (NNRTI) DBREF 2YKN A 1 557 UNP P03366 POL_HV1B1 600 1156 DBREF 2YKN B 1 428 UNP P03366 POL_HV1B1 600 1027 SEQADV 2YKN HIS A 558 UNP P03366 EXPRESSION TAG SEQADV 2YKN HIS A 559 UNP P03366 EXPRESSION TAG SEQADV 2YKN HIS A 560 UNP P03366 EXPRESSION TAG SEQADV 2YKN HIS A 561 UNP P03366 EXPRESSION TAG SEQADV 2YKN HIS A 562 UNP P03366 EXPRESSION TAG SEQADV 2YKN SER A 57 UNP P03366 ASN 656 CONFLICT SEQADV 2YKN LEU A 227 UNP P03366 PHE 826 ENGINEERED MUTATION SEQADV 2YKN GLN A 478 UNP P03366 GLU 1077 ENGINEERED MUTATION SEQADV 2YKN SER B 280 UNP P03366 CYS 879 CONFLICT SEQRES 1 A 562 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 A 562 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 A 562 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 A 562 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 A 562 GLU ASN PRO TYR SER THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 A 562 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 A 562 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 A 562 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 A 562 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 A 562 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 A 562 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 A 562 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 A 562 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 A 562 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 A 562 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 A 562 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 A 562 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 A 562 GLN LYS GLU PRO PRO LEU LEU TRP MET GLY TYR GLU LEU SEQRES 19 A 562 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 A 562 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 A 562 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 A 562 ILE LYS VAL ARG GLN LEU CYS LYS LEU LEU ARG GLY THR SEQRES 23 A 562 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 A 562 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 A 562 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 A 562 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 A 562 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 A 562 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 A 562 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 A 562 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 A 562 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 A 562 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 A 562 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN LEU SEQRES 34 A 562 GLU LYS GLU PRO ILE VAL GLY ALA GLU THR PHE TYR VAL SEQRES 35 A 562 ASP GLY ALA ALA ASN ARG GLU THR LYS LEU GLY LYS ALA SEQRES 36 A 562 GLY TYR VAL THR ASN LYS GLY ARG GLN LYS VAL VAL PRO SEQRES 37 A 562 LEU THR ASN THR THR ASN GLN LYS THR GLN LEU GLN ALA SEQRES 38 A 562 ILE TYR LEU ALA LEU GLN ASP SER GLY LEU GLU VAL ASN SEQRES 39 A 562 ILE VAL THR ASP SER GLN TYR ALA LEU GLY ILE ILE GLN SEQRES 40 A 562 ALA GLN PRO ASP LYS SER GLU SER GLU LEU VAL ASN GLN SEQRES 41 A 562 ILE ILE GLU GLN LEU ILE LYS LYS GLU LYS VAL TYR LEU SEQRES 42 A 562 ALA TRP VAL PRO ALA HIS LYS GLY ILE GLY GLY ASN GLU SEQRES 43 A 562 GLN VAL ASP LYS LEU VAL SER ALA GLY ILE ARG HIS HIS SEQRES 44 A 562 HIS HIS HIS SEQRES 1 B 428 PRO ILE SER PRO ILE GLU THR VAL PRO VAL LYS LEU LYS SEQRES 2 B 428 PRO GLY MET ASP GLY PRO LYS VAL LYS GLN TRP PRO LEU SEQRES 3 B 428 THR GLU GLU LYS ILE LYS ALA LEU VAL GLU ILE CYS THR SEQRES 4 B 428 GLU MET GLU LYS GLU GLY LYS ILE SER LYS ILE GLY PRO SEQRES 5 B 428 GLU ASN PRO TYR ASN THR PRO VAL PHE ALA ILE LYS LYS SEQRES 6 B 428 LYS ASP SER THR LYS TRP ARG LYS LEU VAL ASP PHE ARG SEQRES 7 B 428 GLU LEU ASN LYS ARG THR GLN ASP PHE TRP GLU VAL GLN SEQRES 8 B 428 LEU GLY ILE PRO HIS PRO ALA GLY LEU LYS LYS LYS LYS SEQRES 9 B 428 SER VAL THR VAL LEU ASP VAL GLY ASP ALA TYR PHE SER SEQRES 10 B 428 VAL PRO LEU ASP GLU ASP PHE ARG LYS TYR THR ALA PHE SEQRES 11 B 428 THR ILE PRO SER ILE ASN ASN GLU THR PRO GLY ILE ARG SEQRES 12 B 428 TYR GLN TYR ASN VAL LEU PRO GLN GLY TRP LYS GLY SER SEQRES 13 B 428 PRO ALA ILE PHE GLN SER SER MET THR LYS ILE LEU GLU SEQRES 14 B 428 PRO PHE LYS LYS GLN ASN PRO ASP ILE VAL ILE TYR GLN SEQRES 15 B 428 TYR MET ASP ASP LEU TYR VAL GLY SER ASP LEU GLU ILE SEQRES 16 B 428 GLY GLN HIS ARG THR LYS ILE GLU GLU LEU ARG GLN HIS SEQRES 17 B 428 LEU LEU ARG TRP GLY LEU THR THR PRO ASP LYS LYS HIS SEQRES 18 B 428 GLN LYS GLU PRO PRO PHE LEU TRP MET GLY TYR GLU LEU SEQRES 19 B 428 HIS PRO ASP LYS TRP THR VAL GLN PRO ILE VAL LEU PRO SEQRES 20 B 428 GLU LYS ASP SER TRP THR VAL ASN ASP ILE GLN LYS LEU SEQRES 21 B 428 VAL GLY LYS LEU ASN TRP ALA SER GLN ILE TYR PRO GLY SEQRES 22 B 428 ILE LYS VAL ARG GLN LEU SER LYS LEU LEU ARG GLY THR SEQRES 23 B 428 LYS ALA LEU THR GLU VAL ILE PRO LEU THR GLU GLU ALA SEQRES 24 B 428 GLU LEU GLU LEU ALA GLU ASN ARG GLU ILE LEU LYS GLU SEQRES 25 B 428 PRO VAL HIS GLY VAL TYR TYR ASP PRO SER LYS ASP LEU SEQRES 26 B 428 ILE ALA GLU ILE GLN LYS GLN GLY GLN GLY GLN TRP THR SEQRES 27 B 428 TYR GLN ILE TYR GLN GLU PRO PHE LYS ASN LEU LYS THR SEQRES 28 B 428 GLY LYS TYR ALA ARG MET ARG GLY ALA HIS THR ASN ASP SEQRES 29 B 428 VAL LYS GLN LEU THR GLU ALA VAL GLN LYS ILE THR THR SEQRES 30 B 428 GLU SER ILE VAL ILE TRP GLY LYS THR PRO LYS PHE LYS SEQRES 31 B 428 LEU PRO ILE GLN LYS GLU THR TRP GLU THR TRP TRP THR SEQRES 32 B 428 GLU TYR TRP GLN ALA THR TRP ILE PRO GLU TRP GLU PHE SEQRES 33 B 428 VAL ASN THR PRO PRO LEU VAL LYS LEU TRP TYR GLN HET YKN A1559 20 HET CA A1560 1 HETNAM YKN 2-[DIFLUORO-[(4-METHYL-PYRIMIDINYL)-THIO]METHYL]- HETNAM 2 YKN BENZOXAZOLE HETNAM CA CALCIUM ION FORMUL 3 YKN C13 H9 F2 N3 O S FORMUL 4 CA CA 2+ FORMUL 5 HOH *276(H2 O) HELIX 1 1 THR A 27 GLU A 44 1 18 HELIX 2 2 PHE A 77 THR A 84 1 8 HELIX 3 3 HIS A 96 LEU A 100 5 5 HELIX 4 4 ALA A 114 VAL A 118 5 5 HELIX 5 5 PHE A 124 ALA A 129 5 6 HELIX 6 6 SER A 134 GLU A 138 5 5 HELIX 7 7 GLY A 155 ASN A 175 1 21 HELIX 8 8 GLU A 194 TRP A 212 1 19 HELIX 9 9 THR A 253 SER A 268 1 16 HELIX 10 10 VAL A 276 LEU A 283 1 8 HELIX 11 11 THR A 296 LYS A 311 1 16 HELIX 12 12 ASN A 363 GLY A 384 1 22 HELIX 13 13 GLN A 394 TYR A 405 1 12 HELIX 14 14 THR A 473 SER A 489 1 17 HELIX 15 15 SER A 499 ALA A 508 1 10 HELIX 16 16 SER A 515 LYS A 528 1 14 HELIX 17 17 GLY A 544 ALA A 554 1 11 HELIX 18 18 THR B 27 GLU B 44 1 18 HELIX 19 19 PHE B 77 GLN B 85 1 9 HELIX 20 20 GLY B 99 LYS B 103 5 5 HELIX 21 21 GLY B 112 VAL B 118 5 7 HELIX 22 22 PHE B 124 ALA B 129 5 6 HELIX 23 23 SER B 134 GLU B 138 5 5 HELIX 24 24 LYS B 154 ASN B 175 1 22 HELIX 25 25 GLU B 194 ARG B 211 1 18 HELIX 26 26 HIS B 235 TRP B 239 5 5 HELIX 27 27 THR B 253 GLN B 269 1 17 HELIX 28 28 VAL B 276 LYS B 281 1 6 HELIX 29 29 GLU B 297 GLU B 312 1 16 HELIX 30 30 ASP B 364 GLY B 384 1 21 HELIX 31 31 GLN B 394 TRP B 406 1 13 HELIX 32 32 LEU B 422 TYR B 427 1 6 SHEET 1 AA 3 ILE A 47 LYS A 49 0 SHEET 2 AA 3 ILE A 142 TYR A 146 -1 O GLN A 145 N SER A 48 SHEET 3 AA 3 PHE A 130 ILE A 132 -1 O PHE A 130 N TYR A 144 SHEET 1 AB 2 VAL A 60 ILE A 63 0 SHEET 2 AB 2 ARG A 72 VAL A 75 -1 O ARG A 72 N ILE A 63 SHEET 1 AC 3 SER A 105 ASP A 110 0 SHEET 2 AC 3 ASP A 186 SER A 191 -1 O LEU A 187 N LEU A 109 SHEET 3 AC 3 VAL A 179 TYR A 183 -1 O VAL A 179 N GLY A 190 SHEET 1 AD 3 LEU A 227 TRP A 229 0 SHEET 2 AD 3 TYR A 232 LEU A 234 -1 O TYR A 232 N TRP A 229 SHEET 3 AD 3 TRP A 239 VAL A 241 -1 O THR A 240 N GLU A 233 SHEET 1 AE 5 LYS A 347 TYR A 354 0 SHEET 2 AE 5 TRP A 337 GLU A 344 -1 O TRP A 337 N TYR A 354 SHEET 3 AE 5 ILE A 326 LYS A 331 -1 O ILE A 326 N TYR A 342 SHEET 4 AE 5 LYS A 388 LEU A 391 1 O LYS A 388 N ALA A 327 SHEET 5 AE 5 TRP A 414 PHE A 416 1 O GLU A 415 N LEU A 391 SHEET 1 AF 2 HIS A 361 THR A 362 0 SHEET 2 AF 2 LYS A 512 SER A 513 -1 O LYS A 512 N THR A 362 SHEET 1 AG 5 GLN A 464 LEU A 469 0 SHEET 2 AG 5 GLY A 453 THR A 459 -1 O GLY A 453 N LEU A 469 SHEET 3 AG 5 GLU A 438 ALA A 446 -1 O TYR A 441 N VAL A 458 SHEET 4 AG 5 GLU A 492 THR A 497 1 O GLU A 492 N GLU A 438 SHEET 5 AG 5 LYS A 530 TRP A 535 1 O LYS A 530 N VAL A 493 SHEET 1 BA 3 ILE B 47 LYS B 49 0 SHEET 2 BA 3 ILE B 142 TYR B 146 -1 O GLN B 145 N SER B 48 SHEET 3 BA 3 PHE B 130 ILE B 132 -1 O PHE B 130 N TYR B 144 SHEET 1 BB 2 VAL B 60 LYS B 64 0 SHEET 2 BB 2 TRP B 71 VAL B 75 -1 O ARG B 72 N ILE B 63 SHEET 1 BC 3 SER B 105 ASP B 110 0 SHEET 2 BC 3 ASP B 186 SER B 191 -1 O LEU B 187 N LEU B 109 SHEET 3 BC 3 VAL B 179 TYR B 183 -1 O VAL B 179 N GLY B 190 SHEET 1 BD 5 ASN B 348 ALA B 355 0 SHEET 2 BD 5 GLN B 336 TYR B 342 -1 O TRP B 337 N TYR B 354 SHEET 3 BD 5 ILE B 326 GLY B 333 -1 O ILE B 326 N TYR B 342 SHEET 4 BD 5 LYS B 388 LEU B 391 1 O LYS B 388 N ALA B 327 SHEET 5 BD 5 TRP B 414 PHE B 416 1 O GLU B 415 N LEU B 391 LINK OD1 ASP A 443 CA CA A1560 1555 1555 2.06 LINK O GLY A 444 CA CA A1560 1555 1555 3.17 LINK OE1 GLN A 478 CA CA A1560 1555 1555 2.50 LINK OD1 ASP A 498 CA CA A1560 1555 1555 2.59 CISPEP 1 PRO A 420 PRO A 421 0 -2.85 SITE 1 AC1 12 LEU A 100 LYS A 101 LYS A 103 VAL A 106 SITE 2 AC1 12 VAL A 179 TYR A 181 TYR A 188 GLY A 190 SITE 3 AC1 12 LEU A 234 HIS A 235 TYR A 318 HOH A2162 SITE 1 AC2 4 ASP A 443 GLY A 444 GLN A 478 ASP A 498 CRYST1 119.046 155.576 152.764 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008400 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006428 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006546 0.00000